Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
0.2820
Aug 04 • 1:37 PM ET Dollar change+0.0090 Percentage change(3.30%)
Index
-
Market Cap
4.80M
Enterprise Value
4.01M
Income
-5.10M
Sales
0.52M
Book/sh
0.43
Cash/sh
0.17
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Sep 05, 2024
P/E
-
Forward P/E
-
PEG
-
P/S
9.24
P/B
0.66
P/C
1.64
P/FCF
-
EV/EBITDA
-
EV/Sales
7.72
Quick Ratio
8.72
Current Ratio
8.83
Debt/Eq
0.02
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-0.32
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
-8.37% -7.12%
EPS Y/Y TTM
-591.09%
Sales Y/Y TTM
16.70%
EPS Q/Q
-592.40%
Sales Q/Q
91.63%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
51.40%
Insider Trans
0.00%
Inst Own
0.57%
Inst Trans
-10.27%
ROA
-64.45%
ROE
-82.84%
ROIC
-83.26%
Gross Margin
62.59%
Oper. Margin
-991.71%
Profit Margin
-974.68%
SMA20
-1.96%
SMA50
-9.47%
SMA200
-31.51%
Trades
Shs Outstand
17.05M
Shs Float
8.29M
52W High
1.32 -78.64%
52W Low
0.22 28.65%
Volatility
13.75% 11.25%
ATR (14)
0.04
RSI (14)
47.47
Beta
2.76
Rel Volume
0.08
Avg Volume
847.76K
Volume
43,414
Perf Week
8.88%
Perf Month
-13.12%
Perf Quarter
-19.66%
Perf Half Y
-40.01%
Perf YTD
-32.98%
Perf Year
-71.80%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.27
Price
0.28
Change
3.30%
Jul-15-26 08:30AM
Apr-23-26 04:05PM
Jan-13-26 08:30AM
Dec-05-25 04:05PM
Nov-18-25 03:30AM
04:15PM Loading…
Oct-23-25 04:15PM
Sep-04-25 01:01PM
Aug-18-25 12:00AM
Aug-01-25 09:28AM
Mar-17-25 08:31AM
Sep-06-24 04:08PM
Sep-05-24 09:31AM
iTonic Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.
CEO & Chairman of the BoardMr. Jianfei Zhang
Chief Financial OfficerMs. Zhixin Li